Literature DB >> 25128700

Methoxetamine--a novel recreational drug with potent hallucinogenic properties.

Jolanta B Zawilska1.   

Abstract

Methoxetamine is one of the constantly growing group of novel psychoactive substances that has emerged in recent years. The compound belongs to the arylcyclohexylamine class, which is used for its recreational and psychedelic effects. Methoxetamine is a structural analogue of ketamine, with a much longer duration of action and intensity of effects, and has been extensively advertised as its 'legal' and 'bladder friendly' alternative. This review surveys the current state of knowledge regarding the metabolism, pharmacology, prevalence and pattern of methoxetamine use, and analytical methods of its detection. Consumption of methoxetamine bears a significant health risk and may even lead to fatal intoxication. A significant amount of research is still needed in order to fully quantify the short- and long-term effects of methoxetamine and its interaction with other drugs of abuse.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Hallucinogenic/dissociative drugs; Methoxetamine; Novel psychoactive substances; Toxidrome

Mesh:

Substances:

Year:  2014        PMID: 25128700     DOI: 10.1016/j.toxlet.2014.08.011

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  6 in total

1.  Methoxetamine affects brain processing involved in emotional response in rats.

Authors:  M T Zanda; P Fadda; S Antinori; M Di Chio; W Fratta; C Chiamulera; L Fattore
Journal:  Br J Pharmacol       Date:  2017-08-19       Impact factor: 8.739

2.  The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission.

Authors:  Anna Mutti; Sonia Aroni; Paola Fadda; Laura Padovani; Laura Mancini; Roberto Collu; Anna Lisa Muntoni; Liana Fattore; Cristiano Chiamulera
Journal:  Psychopharmacology (Berl)       Date:  2016-03-28       Impact factor: 4.530

3.  In vitro metabolic profile of mexedrone, a mephedrone analog, studied by high- and low-resolution mass spectrometry.

Authors:  Cristian Camuto; Angelica Guglielmelli; Fabio De-Giorgio; Xavier de la Torre; Monica Mazzarino; Matteo Marti; Francesco Botrè
Journal:  Drug Test Anal       Date:  2021-11-08       Impact factor: 3.234

Review 4.  When good times go bad: managing 'legal high' complications in the emergency department.

Authors:  Charles R Caffrey; Patrick M Lank
Journal:  Open Access Emerg Med       Date:  2017-12-20

5.  "Being with a Buddha": A Case Report of Methoxetamine Use in a United States Veteran with PTSD.

Authors:  Joan M Striebel; Emily E Nelson; Raj K Kalapatapu
Journal:  Case Rep Psychiatry       Date:  2017-01-29

Review 6.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.